Breaking News

Chime Biologics Obtains ISO 27001 Certification for Information Security Management Systems

Strengthens its global information security standards and its ability to be a trusted global partner.

Global CDMO Chime Biologics has obtained ISO/IEC 27001:2022 certification for its information security management systems.
 
ISO 27001 certification is an internationally recognized standard for information security management.
 
Dr. Jimmy Wei, President of Chime Biologics, said, “We are very proud to achieve ISO 27001 certification. As a global CDMO, Chime Biologics has always emphasized on protecting clients’ data and information and has comprehensive experience in data and information security. It is an important milestone that will further strengthen our global information security standards and our ability to be a trusted global partner.”
 
Chime Biologics has three global ISO certifications, including ISO 14001 Environmental management systems certification, ISO 45001 Occupational health and safety management systems certification and ISO 27001 Information security management systems certification, demonstrating its commitment to environment protection, employees’ health and safety, and information security.

More Chime Biologics News

Chime Biologics and Hope Medicine Inc. recently partnered to develop and manufacture the first-in-class monoclonal antibody drug HMI-115.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters